nervous system
• by 12 months of age, ~60% of mice show amyloid beta (Abeta) deposition
(J:78357)
• mice have a higher percentage of thioflavine-S positive Abeta-immunoreactive deposits than Clu-null mice
(J:78357)
• all deposits are surrounded by multiple enlarged, dystrophic neurites
(J:78357)
• a 2-fold increase in monomeric Abeta is detected in the brain compared to Clu-deficient transgenic mice
(J:78357)
• by 12 months of age, mice have amyloid beta (Abeta) deposits in the hippocampus and cortex
(J:107702)
• mice have prominent deposits that are both diffuse and compact in appearance in hippocampus and in molecular layer of dentate gyrus
(J:107702)
|
• dystrophic neurites are 10-fold higher compared to Clu-null transgenic mice and more dystrophic neurites (5-fold) are associated with each amyloid deposit
|
homeostasis/metabolism
amyloidosis
(
J:78357
)
• 77% of mice have thioflavine-S-positive (fibrillar Abeta or amyloid) deposits in the cortex
• hippocampal amyloid burden is greater (2.76%) than in Clu-null transgenics at 12 months of age
|
• by 12 months of age, ~60% of mice show amyloid beta (Abeta) deposition
(J:78357)
• mice have a higher percentage of thioflavine-S positive Abeta-immunoreactive deposits than Clu-null mice
(J:78357)
• all deposits are surrounded by multiple enlarged, dystrophic neurites
(J:78357)
• a 2-fold increase in monomeric Abeta is detected in the brain compared to Clu-deficient transgenic mice
(J:78357)
• by 12 months of age, mice have amyloid beta (Abeta) deposits in the hippocampus and cortex
(J:107702)
• mice have prominent deposits that are both diffuse and compact in appearance in hippocampus and in molecular layer of dentate gyrus
(J:107702)
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Alzheimer's disease | DOID:10652 | J:78357 |